Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act

Compounders may only compound a drug that includes a bulk drug substance that complies with applicable USP or monograph, are components of an FDA approved drug, or appear on the FDA’s 503A bulks list.